History 25 years of sustainable innovation, world-class surgeon education, and an unwavering commitment to improving patient outcomes
Medacta is a family company established in 1999 by Dr. Alberto Siccardi, our Founder, Chairman and former CEO. Following his desire to improve care for patients and considering his personal experience with orthopaedic procedures, Dr. Alberto Siccardi dedicated himself to the development of orthopaedic products and surgical techniques. This dedication spans three generations, with each bringing a unique perspective, experience, and passion. In 2019, we became a publicly listed company, officially entering the SIX Swiss Exchange. Adding to this significant milestone, a generational shift occurred as Francesco Siccardi assumed the role of CEO within the company. Today, Medacta is a global key player thanks to its continuous organic growth.

OUR MILESTONES

1999

In 1999, Dr. Alberto Siccardi, our founder, chairman, and former CEO, established Medacta after his own patient experience convinced him of the importance of pioneering an innovation-centered approach to joint replacement.

2004

Introduced in 2004, AMIS (Anterior Minimally Invasive Surgery) debuted as Medacta’s first minimally invasive hip technique. In the same year, we established the M.O.R.E. (Medacta Orthopaedic Research and Education) Institute to educate and engage with our surgeons.

2019

In 2019, we became a publicly listed company, officially entering the SIX Swiss Exchange. Adding to this significant milestone, a generational shift occurred as Francesco Siccardi assumed the role of CEO within the company.